Qimin Zhan
Peking Union Medical College
215 Papers
1.3K Citations
Qimin Zhan is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Biology & Cancer. The author has an hindex of 54, co-authored 186 publications. Previous affiliations of Qimin Zhan include National Institutes of Health.
Chat about Author
Papers
Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Yongping Cui,Hongyan Chen,Ruibin Xi,Heyang Cui,Yahui Zhao,Enwei Xu,Ting Yan,Xiaomei Lu,Furong Huang,Pengzhou Kong,Yang Li,Xiaolin Zhu,Jiawei Wang,Wenshuai Zhu,Jie Wang,Yan-gang Ma,Yong Zhou,Shiping Guo,Ling Zhang,Yiqian Liu,Bin Wang,Yanfeng Xi,Ruifang Sun,Xiao Yu,Yuanfang Zhai,Fang Wang,Jian Yang,Bin Yang,Caixia Cheng,Jing Liu,Bin Song,Hongyi Li,Yian Wang,Yingchun Zhang,Xiaolong Cheng,Qimin Zhan,YanHong Li,Zhihua Liu +37 more
Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma
Liyan Xue,Yongmei Song,Tong Tong,Wei Luo,Lijia Dong,Shuang-mei Zou,Shan Zheng,Rui Bi,Qimin Zhan,Ning Lu +9 more
TL;DR: Finn and CK14 may play important roles in the carcinogenesis and progression of ESCC and combination of fascin and CK 14 would be valuable markers in diagnosis of ES CC.
3
Erratum: Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions (Nature Genetics (2012) 44 (1090-1097))
Chen Wu,Peter Kraft,Kan Zhai,Jiang Chang,Zhaoming Wang,Yun Li,Zhibin Hu,Zhonghu He,Wei Hua Jia,Christian C. Abnet,Liming Liang,Nan Hu,Xiaoping Miao,Yifeng Zhou,Zhihua Liu,Qimin Zhan,Yu Liu,Yan Qiao,Yuling Zhou,Guangfu Jin,Chuanhai Guo,Changdong Lu,Haijun Yang,Jianhua Fu,Dianke Yu,Neal D. Freedman,Ti Ding,Wen Tan,Alisa M. Goldstein,Tangchun Wu,Hongbing Shen,Yang Ke,Yi Xin Zeng,Stephen J. Chanock,Philip R. Taylor,Dongxin Lin +35 more
TL;DR: The authors find that there is now no evidence to support the association with esophageal squamous cell carcinoma susceptibility of rs17761864 at 17p13, rs6503659 at 17q21 or rs2847281 at 18p11 in the original data.
Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Yongping Cui,Hongyan Chen,Ruibin Xi,Heyang Cui,Yahui Zhao,Enwei Xu,Ting Yan,Xiaomei Lu,Furong Huang,Pengzhou Kong,Yang Liu,Xiaolin Zhu,Jiawei Wang,Wenshuai Zhu,Jie Wang,Yan-gang Ma,Yong Zhou,Shiping Guo,Ling Zhang,Yiqian Liu,Bin Wang,Yanfeng Xi,Ruifang Sun,Xiao Yu,Yuanfang Zhai,Fang Wang,Jian Yang,Bin Yang,Caixia Cheng,Jing Liu,Bin Song,Hongyi Li,Yi Wang,Yingchun Zhang,Xiaolong Cheng,Qimin Zhan,Yanhong Li,Zhihua Liu +37 more
Patent
HULC siRNA and use of HULC siRNA in preparation of drugs for treatment of liver cancer
Qimin Zhan,Dan Li,Yong-mei Song,Tong Tong,Xuefeng Liu,Ming Fu +5 more
- 16 May 2012
TL;DR: In this article, highly up-reglated in liver cancer (HULC) siRNA and a use of the HULC siRNA in preparation of drugs for treatment of liver cancer were discussed.
3